Show simple item record

dc.contributor.advisorKelleher, Dermot
dc.contributor.authorO'Brien, Julie Bridget
dc.date.accessioned2019-05-01T14:33:19Z
dc.date.available2019-05-01T14:33:19Z
dc.date.issued2005
dc.identifier.citationJulie Bridget O'Brien, 'Surface layer proteins of Clostridium difficile as novel vaccine candidates', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Clinical Medicine, 2005, pp 285
dc.identifier.otherTHESIS 8529
dc.identifier.urihttp://hdl.handle.net/2262/86551
dc.description.abstractClostridium difficile is a major cause of antibiotic associated diarrhoea and pseudomembranous colitis in hospitalised patients. The major precipitating factor for C. difficile-associated disease (CDAD) is disruption of the normal gut flora by antibiotic therapy. C. difficile can then colonise the gut and produce the toxins, which mediate much of its pathogenesis. Currently, there is no C. difficile vaccine licensed for human use. A toxin-based vaccine is under development and has shown promise. However, this vaccine will not prevent colonisation and thus transmission is likely to remain a problem. C. difficile expresses two major surface layer proteins (SLPs), the low-molecular weight (MW) SLP and the high-MW SLP, which form a crystalline regular array on its outer surface. A single gene, slpA, encodes a precursor protein which is processed to remove a signal peptide and then undergoes a second cleavage to release the two mature SLPs. The low-MW SLP exhibits a high degree of inter-strain variability and can elicit a serum antibody response in infected individuals. The high-MW SLP is putatively involved in gut colonisation. The SLPs, therefore, represent good novel targets for vaccine development against C. difficile. This study was chiefly concerned with the generation of strong immune responses against the SLPs with a view to developing a vaccine against C. difficile.
dc.format1 volume
dc.language.isoen
dc.publisherTrinity College (Dublin, Ireland). School of Medicine. Discipline of Clinical Medicine
dc.relation.isversionofhttp://stella.catalogue.tcd.ie/iii/encore/record/C__Rb13387671
dc.subjectClinical Medicine, Ph.D.
dc.subjectPh.D. Trinity College Dublin
dc.titleSurface layer proteins of Clostridium difficile as novel vaccine candidates
dc.typethesis
dc.type.supercollectionthesis_dissertations
dc.type.supercollectionrefereed_publications
dc.type.qualificationlevelDoctoral
dc.type.qualificationnameDoctor of Philosophy (Ph.D.)
dc.rights.ecaccessrightsopenAccess
dc.format.extentpaginationpp 285
dc.description.noteTARA (Trinity's Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record